Serum hepatitis has recently become amenable to laboratory study, in spite of the fact that the virus which causes it has not yet been isolated 2 . Much of the interest in the disease has centred around the patients and staff of renal dialysis units 3 and those involved in renal transplantation, but the treatment of chronic renal failure is only one of a number of situations involving operative treatment of the patient and the transfusion of large volumes of blood, either as repeated small transfusions or as a large quantity given at once. Transplant surgery and major cardiac survery are, like renal dialysis, procedures which twenty years ago were performed on relatively few patients, but have now become routine measures practised widely on relatively large numbers of patients, and they too have contributed to the increase in the quantities of blood and plasma transfused. There has also been an increasing range of blood products, such as anti-haemophilic globu-lin, cryoprecipitate, concentrated platelets and radioiodine-labelled fibrinogen, some of which are available as preparations pooled from several donors. In addition, some of these situations involve either artificial suppression of the immune response, as after transplants, or a natural diminution in this response, as in the uraemic patients on long-term renal dialysis.
There has also been a steady increase in the number of surgical operations, and in elaborate diagnostic procedures such as cardiac catheterization and various radiological investigations, all entailing at least some spillage of the patient's blood and its contact with doctors and perhaps other patients. The application of these techniques has of course entailed an enormous increase in laboratory investigations involving the handling of samples of blood and serum. This increase in the scale of laboratory investigation extends also to non-surgical patients, for example to those undergoing intensive therapy for leukaemia or chorion-carcinoma, such therapy involving the combination of blood transfusion and immuno-suppression.
It is now known with certainty, from experiments with human volunteers, that serum hepatitis (SH)
is caused by a filterable agent, which is presumed to be a virus, and that it is different serologically and biologically from the agent of epidemic infective hepatitis (HI) which is also thought to be a virus. Biologically, the principal difference is the dependence of SH virus upon artificial procedures for its transmission, although it is now clear that it can, even if less readily, be passed, too, by the oral route, as IH can, and probably by air-borne spread also. The practical development which has made SH more accessible to study is the discovery of the Australia antigen, a substance found in the blood of patients at some stage of the disease, and of symptomless carriers 4 . The exact constitution of Australia antigen varies from patient to patient, particularly in the proportion of the characteristic large particles first described by DANE, CAMERON and BRIGGS 5 , particles which are at present believed to represent the virus itself. The Australia antigen, and also antibody to it, can be detected by various serological techniques 6 . Besides the confirmation of its association with the disease itself, the techniques now to hand have enabled the mapping of its geographical distribution and hence, by extrapolation, the virus, throughout much of the world. Its distribution is high in the countries and islands of the Pacific, in the accessible parts of South-east Asia generally, in tropical Africa and in central and southern America. It is much lower in northern America and North west Europe. A high incidence of the antigen in an area is usually associated with a high carrier rate, but not necessarily with a high incidence of the disease, at least in a clinically obvious form.
It is generally supposed that there has been an increased incidence of SH in recent years in various developed countries, especially Japan and the U.S.A. 
The recognition of serum hepatitis as an entity
It is now nearly 100 years since the first clearly identifiable outbreak of SH in an area of low r Australia antigen incidence was reported, and some of the principal recorded and well documented outbreaks between then and the time when the entity of "homologous serum jaundice" was recognised 9 are given in The matter of transmission of SH by medical procedures came to a head almost simultaneously over measles prophylaxis using human serum, on the one hand 9 ' 16 , and over yellow fever vaccination using T h e i 1 e r's 17D vaccine containing human serum on the other 17 ' 18 . By this time, i. e. the middle of World War II, human serum used for prophylaxis of other infections, e. g. mumps, had also become involved, as well as other procedures, as summarised in Table 1 . During World War II the term "homologous serum jaundice" was coined, and the unity of the syndrome, and hence probably the uniformity of the causative agent, recognised 9 ' 19 .
Types of procedure involved in transmission of serum hepatitis
It will be seen from the last column of Table I that there are four principal categories of procedure which helped to bring SH to light as a disease entiry. These were: - These four procedures differ in the date of their introduction and widespread adoption, in the quantity of material transferred from one patient to another, and in the ages both of the donors and the recipients. These differences will be considered in each case, and with particular regard to the likelihood of the procedure causing either the disease SH, or disseminating the virus in such a way as to produce the carrier state in the recipient.
Vaccination against virus diseases -This has
not ceased to be practised since the time of Jenner. It seems to have been a common practice to add human serum, usually of rather uncertain provenance, to vaccines. From the data given by LÜR-MAN 10 , the outbreak in Bremen in 1883 was attributable to the human serum in particular batches of vaccine, but the hygiene of medical practice in the 1880's had scarcely emerged from pre-Listerian days, and JEHN'S outbreak in the institution at Merzig 11 may well have originated, as suggested above, with one of the mental defective inmates rather than with the smallpox vaccine itself. The cases arising from yellow fever vaccination 60 years later are undoubtedly attributed to the human serum in the vaccine. The quantity of serum was relatively small, because of dilution in the vaccine, it came from adults, and the recipients were principally adults. However, it is significant that in the mass vaccination against yellow fever performed about the same time in Brazil, the incidence of overt jaundice in children was less than that in adults receiving the same batch of vaccine 18 . The significance of this difference will be discussed later.
Transmission by syringes and other instru-
ments -This came to light next, and may have arisen from the introduction of organic arsenical compounds for the therapy of syphilis in the 1900's. The mechanism of transmission here probably differed from that causing SH among diabetics, in whom it is more likely to have been caused by finger pricks for blood sugars than by the use of communal syringes. The quantity of material transferred would be comparatively small, and both donors and recipients would be largely, though by no means exclusively, adolescents or adults.
The transfusion of blood and blood products -
Blood transfusion, although adopted before 1914, and although receiving some impetus from the 1914 -18 war, was not practised, even in countries with advanced and sophisticated medical practice, on any large scale until the mid-1930's. It received a great impetus from the need for organised services for civilian and service casualties in the 1939 -1945 war, and the use of pooled plasma was introduced about 1940-41. The work of COHN 20 and his colleagues on blood proteins in the 1930's paved the way for the adoption of gamma-globulin about 1944 21 ' 22 , but this was not widespread until the 1950's. Leaving aside gamma-globulin and specific blood products, it may be said that blood transfusion involves what is by microbiological standards a very high dose of material passing from donor to recipient, and that, while donors were virtually exclusively adult, recipients were principally, but by no means exclusively, adults, since even babies received blood transfusions, in spite, of the technical difficulties, quite early after blood transfusion became a generally available measure.
The serophrophylaxis of bacterial and viral in-
fections with human serum -The infections concerned in this fourth category, are principally pertussis 23 , mumps 2i ' 25 , and measles, although human serum was also tried for the prophylaxis of varicella 26 . In the sheer quantity of prophylaxis performed, and the seriousness of the disease, measles overshadows all the others. There seems to be no outbreak of SH attributable to seroprophylaxis for pertussis, although from the report of SMITH 23 in 1936 it is clear that human serum was being used quite extensively for the purpose at that time. The use of convalescent serum for the prophylaxis of mumps seems to have been on a lesser scale than for either pertussis or measles, but SH did follow its use in British and United States troops in World War II 24 ' 25 . This leaves measles, a disease against which seroprophylaxis was practised, in the years between 1916 (its earliest known large scale use 27 ) and about 1950 (by which time it was falling into disrepute) on a scale much greater than may be generally realized.
Compared with the three previous categories of procedure (viz. inoculation of vaccines containing human serum, syringe transmission and the transfusion of blood), there are interesting differences in the circumstances of measles prophylaxis. The donors were at first all convalescent children [28] [29] [30] who could yield only small volumes of blood, and the rare convalescent teenager or adult must have been a much sought-after individual. Later it was appreciated that, because almost every adult had in child-hood suffered from measles, non-specific adult serum was also effective [30] [31] [32] although it needed to be used in larger doses. The volumes used, compared with the size and age of the recipient, were often relatively large for a small child, e. g. up to 40 ml, either of whole blood or of serum.
The procedure was highly effective, and in view of the then prevailing mortality of measles in certain groups of children, can well be justified. More and more serum from adults was used, and pooling became the accepted procedure, although in fact the use of pooled serum had been reported early by RICHARDSON and CONNOR 29 in 1919 . Indeed it was the use of a pool of 880 ml of sera from no less than 26 donors which caused the severe outbreak in England in 1937 reported by MACNALTY involving 41 cases with 8 deaths 16 . This first brought the danger to light, and yet, surprisingly, did not bring the procedure into disrepute, for the use of measles convalescent serum seems to have continued well into the 1950's, in spite of the introduction, effectiveness and safety of gamma-globulin 33 . While it may be argued that it was the use of larger and larger pools of adult serum which increased the chance of a disaster eventually occurring, another explanation is possible. It may be that from about 1920 onwards a generation had been temporarily protected, passively, against measles, but seeded, some of them permanently, i. e. as carriers, with the SH virus, and when they, as adolescents or young adults, contracted measles, the next generation of children, recipients of their serum, developed hepatitis in sufficient numbers to draw attention to the phenomenon.
Considerations in the use of human serum in the prophylaxis of measles
Justification jor the procedure: Because of the low mortality of measles in the developed countries today it may be forgotten how high the mortality has been in the past, let alone the trail of complications and sequelae. So far as mortality is concerned, for example, this was 5.8% in children over 5 (and much higher at ages below this) in Glasgow in 1908. In comparison with other diseases at this time, measles killed more children in Vienna 30 in 1912 than scarlet fever, pertussis and diphtheria put together. In the years 1891 -1900 the mortality was 10.99% in the poorest quarters of the city and only 0.55% in the richest. In 1913 in the U.S.A. there was 8,108 deaths from measles as compared with 4,588 from scarlet fever 29 . In the years 1900 to 1911 in the U.S.A. it is estimated that 100,000 children died from measles and, in New York City as late as 1922 there were 977 deaths from measles 32 .
These figures, selected somewhat at random, show that the problem at that time was a serious one, and that the burden fell on the poorest children. In particular it fell upon institutionalised children, and in infants' homes a mortality as high as 26% has been recorded in an outbreak in Central Europe. There was therefore a real urgency and a genuine justification for attempting to prevent the disease if possible, and to contain an outbreak when one occurred.
The scale oj seroprophylaxis against measles: It is not surprising that the rise of serotherapy and the great success of diphtheria antitoxin, as well as the then reasonably justified view that human sera were sterile fluids (provided syphilis and tuberculosis had been excluded), should lead to the suggestion of the use of human sera as a source of antibodies against measles. Once it had been tried and found to be effective there was justification for further extension and its use on as large a scale as possible. Admittedly the protection given was only passive, but it could stave off the disease until the child was older and it could prevent or contain an institutional outbreak. In 1923 DEBRE and REVINA 34 showed that it could, if given at the right time, help to confer a permanent active immunity, and this provided even further justification for the procedure. There is evidence that the technique was in widespread use on a large scale throughout the 1920's and 1930's. For example DEGKWITZ in Munich in 1921 had a highly organised service 30 and was issuing at least 1500 doses of anti-measles serum a year. Some idea of the extent of the practice can be gleaned from Table 2 . For example, in 1930 children were being immunised at the rate of some 3000 a year in New York, a city whose population at that time was about 6,000,000 35 . It was not until 1937 that the occurrence of jaundice was first reported by MACNALTY 16 in England, the outbreak concerned being that previously mentioned, with 41 cases and 8 deaths. In the same year, PROPERT 36 reported seven cases in an institution for mental defectives, and later others were found.
The incrimination of this procedure in the spread of serum hepatitis: It may be asked why a period of about 20 years elapsed between the first use of measles prophylaxis with human serum and the realization that serum hepatitis could be transmitted in this way. The reasons are various, complex and in some respects interconnected with each other: a) Lack of recognition of the connection with the inoculation -The incubation period of SH is so long that the connection with the prophylactic inoculation was not easily recognised, or the case of jaundice could have merged into the background of infective hepatitis prevailing at the time. There was apparently little organised follow-up once the danger of measles was over, or only a brief one, although HAAS and BLUM 37 mention a period of 16 months in their study. b) Lack of risk from the donor -At first small quantities were used and sera were not usually pooled. Then, to even out the effect of the poor antibody producers, and also for convenience, sera were pooled. Then large doses were given when it was realized that protection was dose-dependent, and when an adolescent (or even more rarely an adult) convalescent case was available. step was that non-convalescent adult serum, i. e.
serum, or sometimes blood, from anyone who had had measles (and this meant virtually all adults) was used. When the effectiveness even of this material was also realized, these sera began to be pooled also, and it is almost certainly significant that the outbreak mentioned above which brought the matter to light was caused by a pool from no less than 26 donors 16 . 
Consequences and implications
It is interesting to note from Table 1 The present situation with regard to serum hepatitis is one largely of our own creation, but it is a situation which is not beyond our control. It can be contained by good techniques, and the SH virus should be treated with respect rather than panic. It will always remain a hazard until every individual is, in as full a sense as possible, a medical island.
Nevertheless, it is likely that acute serum hepatitis and chronic non-malignant liver disease are likely to increase in incidence, and indeed there is reason to suspect that the first of these two is doing so.
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